In order to evaluate that only the simultaneous targeting in the presence of anti-CEA and anti-EpCAM RevTMs triggers a full activation and cytotoxic potential of the Dual-RevCAR T-cells upon their encounter with CEA+ EpCAM+ cancer cells, cytotoxic assays were performed. This evidence concerns the gene EPCAM and cancer.